About 15–25% of GLP-1 users get some diarrhea, especially in week 1 of each new dose. Most of it is mild looseness that resolves in 3–4 days. A subset gets persistent watery diarrhea that turns into dehydration and, occasionally, acute kidney injury. The shape of the curve matters — if it isn't improving by day 5, it isn't normal.
| Day after new dose | Typical stool pattern | Acceptable? |
|---|---|---|
| Day 1 | Normal or slightly soft | Yes |
| Day 2–4 | Soft to loose; 1–3 BMs/day | Yes — peak of GI effect |
| Day 5–7 | Returning toward normal | Yes |
| Day 8+ | Normal pre-dose pattern | Yes |
Loose stool 1–2 times per day for 3–4 days is well within normal. It doesn't require intervention beyond standard hydration.
| Pattern | What it means | Action |
|---|---|---|
| Watery diarrhea ≥5 days | Sustained large-volume fluid loss | Oral rehydration solution; call prescriber if no improvement in 24 hours |
| Diarrhea + vomiting + can't keep water down | Acute dehydration risk | Urgent care or ER for IV fluids |
| Bloody or black stool | Lower or upper GI bleed | ER same day |
| Fever + diarrhea | Possible bacterial GI (C. diff, Salmonella) — not GLP-1 | Stool culture; ER if severe |
| Severe abdominal pain + diarrhea | Possible pancreatitis or cholecystitis | Stop drug; ER same day |
| Diarrhea + reduced urine output | Dehydration, possible AKI | Urgent care |
Watery diarrhea can lose 500–1500 mL of fluid per day. Combined with reduced food/water intake from GLP-1 suppression, the negative balance compounds. Dehydration alone causes nausea and weakness; combined with persistent vomiting it can produce acute kidney injury within 48–72 hours.
Real-world reports of AKI in GLP-1 users almost always involve diarrhea + vomiting + insufficient fluid replacement, not the drug toxicity itself. The kidneys aren't directly damaged; they're hypoperfused from volume loss.
Plain water replaces volume but not electrolytes. Severe diarrhea depletes sodium, potassium, and chloride. Replacing only water can dilute remaining electrolytes and cause hyponatremia.
Target: ~3 L of fluid intake per 24 hours during active diarrhea, half of which should contain electrolytes.
Loperamide (Imodium) is effective at slowing motility but has caveats on GLP-1:
If you're still having daily loose stool at week 3 of a new titration step, the gut hasn't fully adapted. Advancing on schedule guarantees worse diarrhea in the next dose. Hold the current dose for another 4 weeks before the next step.
Mild looseness day 2–3 is common even in maintenance. Frank diarrhea every week is unusual and worth raising — may suggest the dose is at the edge of your tolerance.
Limited evidence. Probiotics help some bacterial-imbalance diarrhea but GLP-1 diarrhea is mostly motility-driven. Worth trying for chronic mild diarrhea; not a substitute for hydration.
Indirectly. High-fat or very-sugar-rich meals can speed transit on top of the drug effect, producing diarrhea. Sugar-free sweeteners (sorbitol, xylitol) are common GI offenders — check for them in low-calorie products.
A small amount, yes — chronic 500 mL/day fluid loss + some malabsorption = ~1–2 kg/week of apparent weight loss that's mostly fluid. The actual fat-loss effect of the drug is separate.
Peptide Protocol tracks fluid and electrolyte intake during diarrhea episodes, flagging dehydration risk before it escalates.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.